Evaluation of G-CSF activity given by intramuscolar (I.M.) route in ovarian cancer patients receiving mitoxantrone (DHAD) + ifosfamide (IFO) as second-line (SL) therapy

✍ Scribed by Di Leo, A.; Bajetta, E.; Nolè, F.; Raspagliesi, F.; Riboldi, G.; Spatti, G.B.; Biganzoli, L.; Bochicchio, A.M.; Taiana, A.; Zanon, P.; Di Re, F.

• Book ID: 121934016
• Publisher: Elsevier Science
• Year: 1993
• Tongue: English
• Weight: 171 KB
• Volume: 29
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/0959-8049(93)90887-L